<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1155/2007/19564</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>Association of <italic>GST</italic> Genes Polymorphisms with Asthma in Tunisian Children</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hanene</surname><given-names>Chelbi</given-names></name><xref rid="a1" ref-type="aff"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jihene</surname><given-names>Lachheb</given-names></name><xref rid="a1" ref-type="aff"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jamel</surname><given-names>Ammar</given-names></name><xref rid="a1" ref-type="aff"><sup>1, 2</sup></xref><xref rid="a2" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Kamel</surname><given-names>Hamzaoui</given-names></name><xref rid="a1" ref-type="aff"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Agn&#x000e8;s</surname><given-names>Hamzaoui</given-names></name><xref rid="a1" ref-type="aff"><sup>1, 2</sup></xref><xref rid="a2" ref-type="aff"/></contrib></contrib-group><aff id="a1"><sup>1</sup>Homeostasis and Cell Dysfunction Unit Research 99/UR/08-40, Faculty of Medicine, University of Tunis El Manar II, Tunis 1007, Tunisia</aff><aff id="a2"><sup>2</sup>Department of Respiratory and Pediatric Diseases, Pneumology Hospital A. Mami, Ariana 2080, Tunisia</aff><author-notes><corresp id="cor1">*Hamzaoui Kamel: <email>kamel.hamzaoui@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><year>2007</year></pub-date><pub-date pub-type="epub"><day>19</day><month>3</month><year>2007</year></pub-date><volume>2007</volume><elocation-id>19564</elocation-id><history><date date-type="received"><day>8</day><month>11</month><year>2006</year></date><date date-type="rev-recd"><day>26</day><month>1</month><year>2007</year></date><date date-type="accepted"><day>27</day><month>1</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Chelbi Hanene et al.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p><italic>Background</italic>. A positive association between genetic polymorphism and asthma may not be extrapolated from one ethnic group to another based on intra- and interethnic allelic and genotype frequencies differences. <italic>Objective</italic>. We assessed whether polymorphisms of <italic>GST</italic> genes (<italic>GSTM1</italic>, <italic>GSTT1,</italic> and <italic>GSTP1</italic>) are associated with asthma and atopy among Tunisian children. <italic>Methods</italic>. 112 unrelated healthy individuals and 105 asthmatic (73 atopic and 32 nonatopic) children were studied. Genotyping the polymorphisms in the <italic>GSTT1</italic> and <italic>GSTM1</italic> genes was performed using the multiplex PCR. The GSTP1 ILe105Val polymorphism was determined using PCR-RFLP. <italic>Results</italic>. <italic>GSTM1</italic> null genotype was significantly associated with the increased risk of asthma (<italic>P</italic> = .002). Asthmatic children had a higher prevalence of the GSTP1Ile105 allele than the control group (43.8% and 33.5%, respectively; <italic>P</italic> = .002). Also, the presence of the GSTP1 homozygote Val/Val was less common in subjects with asthma than in control group. We have found that <italic>GSTT1</italic> null genotype (<italic>GSTT1</italic> *0/*0) was significantly associated with atopy (<italic>P</italic> = .008). <italic>Conclusion</italic>. Polymorphisms within genes of the <italic>GST</italic> superfamily were associated with risk of asthma and atopy in Tunisia.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>Asthma is a chronic disease characterized by reversible airflow obstruction and airway inflammation that affect many people. There is evidence that a genetic predisposition may also alter the capability of the airway to protect itself against inhaled toxic substances from the environment [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>].</p><p>Several candidate genes were implicated in the development of atopy and asthma. It has been reported that prevalence of these candidate genes can vary considerably by ethnicity [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>]. Furthermore, data from given studies suggest that a positive association between genetic polymorphism and asthma or atopy may not be extrapolated from one ethnic group to another based on intra- and interethnic allelic and genotype frequencies difference.</p><p>In North Africa, and especially in Tunisia, research data on this subject is absent. That is why we selected among asthmatic candidate genes three genes that have been known to manifest remarkable inter- and intraethnic differences [<xref ref-type="bibr" rid="B5">5</xref>]. These genes are <italic>GSTT1</italic>, <italic>GSTM1</italic>, and <italic>GSTP1</italic>, which are the code names for enzymes belonging to the glutathione S-transferase (<italic>GST</italic>) super family. In humans, <italic>GSTs</italic> represent a large and diverse super family of enzymes, with at least 13 <italic>GST</italic> enzymes belonging to five different families: mu, theta, alpha, pi, and gamma. The <italic>GSTM1</italic>, <italic>GSTT1</italic>, and <italic>GSTP1</italic> belong, respectively, to the GSTmu, GSTtheta, and GSTpi categories of enzymes. <italic>GSTs</italic> are known to play an important role in the functioning of antioxidant defences through reactive oxygen species (ROS) metabolism, in the repairing of damaged ROS and in the detoxification of several xenobiotics such as carcinogens found in tobacco smoking [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>]. The role played by <italic>GSTs</italic> may be especially important in response to oxidative stress [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B8">8</xref>]. Common homozygote deletion polymorphisms of the <italic>GSTM1</italic> and <italic>GSTT1</italic> genes, as well as the GSTP1Ile105 polymorphism, have been known to abolish enzymes activity and increase susceptibility to oxidative stress [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B8">8</xref>]. Studies have so far reported contradictory results regarding any association between <italic>GST</italic> gene polymorphisms and asthma and/or atopy. In fact, some have reported the presence of an association between GSTP1VAL105Ile polymorphisms and bronchial hyper responsiveness (BHR), asthma and atopy [<xref ref-type="bibr" rid="B9">9</xref>&#x02013;<xref ref-type="bibr" rid="B16">16</xref>]. However, other studies have found no such evidence of any association between polymorphism and asthma or atopy [<xref ref-type="bibr" rid="B17">17</xref>]. In several studies, null alleles in the <italic>GSTT1</italic> and <italic>GSTM1</italic> genes (GSTT1*0 and GSTM1*0) were associated with childhood asthma [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>] but this finding was contradicted in other studies [<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Although there is a high incidence of asthmatic diseases in Tunisia, no data has been reported in this country. In this study we assess whether polymorphisms of <italic>GST</italic> genes previously found to be associated with asthma and atopy in Caucasian and Asiatic subjects are also to be associated with asthma and atopy in Tunisian children.</p></sec><sec sec-type="section" id="sec2"><title>2. SUBJECTS AND METHODS</title><sec sec-type="subsection" id="subsec2.1"><title>2.1. Study subjects</title><p>Asthmatic children's histories were recorded using standard questionnaire categories: age, sex, exposure to tobacco smoke, and family history of asthma and allergy.</p><p>A total of 105 asthmatic children ranging from ages of 5 to 16 years (mean 11.5) were enrolled in this study along with 112 control individuals (aged 5 to 16 years, mean 9.5). None had any recent illnesses requiring treatment and no history of chronic diseases. All lived in the countryside near Tunis, in a town called Ariana. This region is generally considered to be representative of the general Tunisian population. Our national ethics committee approved the study.</p></sec><sec sec-type="subsection" id="subsec2.2"><title>2.2. Total IgE and Prick test assays</title><p>Atopy was defined by the skin sensitivity to specific allergens (skin reaction with a mean weal diameter &#x02265; 3 mm larger than that produced with one or more antigens in the presence of positive histamine control and a negative uncoated control) and by measurement of the total IgE level. Positive values were taken to be &#x02265; 200 UI/ml.</p><p>Among the 105 asthmatic children there were 73 atopic and 32 nonatopic children who had negative skin test responses to common allergens. In our study, asthma is frequently related to a heterogeneous group of clinical disorders including rhinitis, sinusitis, and dermatitis. The clinical profiles are shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p></sec><sec sec-type="subsection" id="subsec2.3"><title>2.3. DNA isolation</title><p>The genomic DNA for genotyping was isolated from 10 ml of peripheral blood lymphocytes which were collected, using a salting-out DNA extraction procedure [<xref ref-type="bibr" rid="B19">19</xref>], in an EDTA containing a vacutainer.</p></sec><sec sec-type="subsection" id="subsec2.4"><title>2.4. GSTM1 and GSTT1 genotypes</title><p>The <italic>GSTM1</italic> and <italic>GSTT1</italic> null genotypes were detected using a multiplex PCR method [<xref ref-type="bibr" rid="B20">20</xref>]. Briefly, 100 ng of DNA were amplified in a-50 ul multiplex reaction mixture containing 0.90 pmol of each of the following GSTM1 primers (GSTM1-F: TTCCTCACTGGTCCTCACATCTC and GSTM1-R: TCACCGGATCATGGCCAGCA) and GSTT1 primers (GSTT1-F: GAACTCCCTGAAAAGCTAAAGC and GSTT1-R: GTTGGGCTCAAATATACGGTGG). As an internal control, the <italic>ALBUMIN</italic> gene was also amplified with 0.2 pmol of each primer (AlbF: GCCCTCTGCTAACAAGTCCTAC and AlbR: GCCCTAAAAAGAAAATCGCCAATC) in a medium consisting of 3.5 mM <chem-struct>MgCl<sub>2</sub></chem-struct>, 200 uM dNTPs, 5 ul 10X PCR buffer, and 2U TaqDNA polymerase. The PCR protocol included an initial melting temperature of 94&#x000b0;C (5 minutes) followed by 35 cycles of amplification (20 seconds at 94&#x000b0;C, 20 seconds at 64&#x000b0;C, and 30 second at 72&#x000b0;C). A final 7-minute extension step (72&#x000b0;C) terminated the process.</p><p>The PCR products were analyzed on agarose gels. A fragment of 215 pb indicated the presence of GSTM1; a fragment of 480 pb indicated the presence of <italic>GSTT1</italic>; and a fragment of 380 pb indicated the positive internal control albumin. The subjects were classified as either (+), when at least one specimen of the gene was detected, or (&#x02212;) when they showed a null genotype. Heterozygous individuals with <italic>GSTM1 </italic><italic>(GSTM1+/&#x02212; and GSTM1+/+)</italic> or <italic>GSTT1 </italic><italic>(GSTT1+/&#x02212; and GSTT1+/+)</italic> were reported to present similar enzymes activity [<xref ref-type="bibr" rid="B21">21</xref>] and expression levels [<xref ref-type="bibr" rid="B22">22</xref>] and were pooled together for statistical analysis.</p><sec sec-type="subsubsection" id="subsubsec2.4.1"><title>2.4.1. GSTP1 genotype</title><p>GSTP1 313A&#x02192;G polymorphism (resulting in Ile105Val at codon 105) was analyzed by PCR-restriction fragment length polymorphism (RFLP) analysis [<xref ref-type="bibr" rid="B23">23</xref>]. Genomic DNA (100 ng) was used as a DNA template in a total 50 <italic>&#x003bc;</italic>l volume reaction. The PCR products were digested in 25 <italic>&#x003bc;</italic>l for 2 hours at 37&#x000b0;C with 5U Alw261. The digested products were then separated with 3% agarose gel stained with ethidium bromide. The presence of a-176 pb fragment indicated the wild-type genotype, whereas the 85 and 91 pb fragments indicated the homozygous polymorphic genotype. Heterozygous individuals recorded all three types of fragments.</p></sec></sec></sec><sec sec-type="section" id="sec3"><title>3. STATISTICAL ANALYSIS</title><p>Association analysis in our case-control study was performed using standard Chi-squared test (Epistat statistical package, Epi Info Version 6) to detect differences in genotypes and alleles distribution among our groups.</p><p>Correction for multiple comparisons was performed, and only the value of corrected <italic>P</italic> &#x0003c; .05 was considered to be significant.</p></sec><sec sec-type="section" id="sec4"><title>4. RESULTS</title><sec sec-type="subsection" id="subsec4.1"><title>4.1. Case-control analysis</title><p>The association between <italic>GST</italic> genotype and susceptibility was studied in 105 unrelated asthmatic children residing in the northern part of Tunisia, using a control group of 112 healthy children.</p><p><xref ref-type="table" rid="T1">Table 1</xref> summarizes the clinical characteristics of subjects conducted in this study. In total, 35% of asthmatic children and 22% of nonasthmatic children were passive smokers. With an average age of 11.5 (ranging between 5 and 16 years), 70.32% of the asthmatic children were diagnosed as atopic.</p><p><xref ref-type="table" rid="T2">Table 2</xref> summarizes the data found regarding the genotype frequencies for the RFLP in the <italic>GSTP1</italic> gene, as well as the homozygous deletions of the <italic>GSTM1</italic> and <italic>GSTT1</italic> genes. Genotype frequencies (<italic>GSTP1</italic>, <italic>GSTM1</italic>, and <italic>GSTT1</italic>) were within the Hardy-Weinberg equilibrium for control population.</p><p>We found that <italic>GSTM1</italic> null genotype was significantly associated with increased risk of asthma (<italic>P</italic> = .002). Indeed, the <italic>GSTM1</italic> null genotype was present among 70.7% of the asthmatic children and among 50.2% of the control group.</p><p>As for the <italic>GSTP1</italic>, the homozygote <italic>GSTP1</italic> Val/Val genotype was less common among the asthmatic patients than in the control group (10.7% versus 18.6%, <italic>P</italic> = .04). Subjects with the <italic>GSTP1Val/GSTP1Val</italic> genotype registered a-2.33 fold lower risk of asthma than those with the <italic>GSTP1Ile/Ile</italic> genotype (OR = 2.33, 95% CL 0.94&#x02013;5.87). Between both study samples, there was a significant difference in the frequency of the GSTP1 alleles (<italic>P</italic> = .02): asthmatic children had a higher prevalence of the GSTP1Ile allele than those in the control group (43.8% and 33.5%, resp.).</p><p>The presence of the <italic>GSTT1</italic> null polymorphism was compared in both sample groups. The difference showed to be nonsignificant (<italic>P</italic> &#x0003e; .05) between controls and asthmatics, 29.5% and 37.5%, respectively, see (<xref ref-type="table" rid="T2">Table 2</xref>).</p></sec><sec sec-type="subsection" id="subsec4.2"><title>4.2. GST genes and atopy</title><p><xref ref-type="table" rid="T3">Table 3</xref> summarizes the association between <italic>GST</italic> genes and atopy.</p><p>The <italic>GSTT1</italic> null genotype (GSTT1*0/*0) was significantly higher in atopic asthmatic cases than in nonatopic asthmatic subjects (<italic>P</italic> = .008). As for the <italic>GSTM1</italic>, there was a-1.5 fold increased risk of atopic asthma in individuals with the <italic>GSTM1</italic> null genotype (OR = 1.5; 95% CI, 0.6&#x02013;3.83), but this increase was not significant. No significant associations have been found between atopy and GSTP1 polymorphism in present study.</p></sec><sec sec-type="subsection" id="subsec4.3"><title>4.3. Polymorphisms of glutathione S-transferase M1, T1, and P1 in a Tunisian control population</title><p>Human cytosolic <italic>GSTs</italic> have been well documented; they are polymorphic and have ethnic-dependent polymorphism frequencies. Compared with research carried out in other countries, the distribution of the <italic>GSTM1</italic> null genotype and the <italic>GSTT1</italic> null among our group of control was found to be, respectively, 50.2% and 29.5% (<xref ref-type="table" rid="T4">Table 4</xref>). Their GSTP1 polymorphism frequencies for the Ile/Ile genotype registered at 34.4%, at 47.1% for the Ile/Val genotype, and at 18.6% for the Val/Val genotype (<xref ref-type="table" rid="T2">Table 2</xref>). The Ile allele frequency for this particular group was set at 0.562.</p></sec></sec><sec sec-type="section" id="sec5"><title>5. DISCUSSION</title><p>The glutathione S-transferase (<italic>GST</italic>) super family of enzymes has a vital role in phase II of biotransformation of xenobiotics and in protection of cells from reactive oxygen species (ROS) by its ability to utilize substrates of a wide range of products of oxidative stress [<xref ref-type="bibr" rid="B6">6</xref>]. Oxidative stress was reported to be the key component of inflammation. Inflammation was considered a characteristic of asthma disease when it attacked airways. So defect in detoxifying ROS may influence the development and severity of asthma.</p><p>The results of our works suggest the presence of associations of <italic>GSTM1</italic>, T1, and P1 with childhood asthma and atopy. In comparing asthmatic children to healthy controls we have demonstrated a significant association between subjects lacking <italic>GSTM1</italic> activity and asthma (<italic>P</italic> = .002). Numerous studies have demonstrated a significant association between subjects lacking <italic>GSTM1</italic> activity and the risk of developing a form of lung disease [<xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B32">32</xref>]. For asthmatics, the association with <italic>GSTM1</italic> null genotype has been reported in Caucasian population [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>] but not in Asiatic groups [<xref ref-type="bibr" rid="B35">35</xref>].</p><p>As for the <italic>GSTP1</italic>, we have also found significant differences between our two study samples regarding the genotype frequencies of the GSTP1Ile105Val polymorphisms. Indeed, asthmatic children have low frequency of GSTP1Val allele compared with healthy children (<italic>P</italic> = .002). The defensive role of the <italic>GSTP1</italic> in cases of asthma was reported in several studies [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>&#x02013;<xref ref-type="bibr" rid="B15">15</xref>]. It was reported that the presence of <italic>GSTP1Val/Val</italic> genotype conferred a sixfold lower risk of asthma than did GSTP1Ile/Ile and that the frequency of <italic>GSTP1Val/Val</italic> genotype correlated negatively with severity of airway dysfunction [<xref ref-type="bibr" rid="B9">9</xref>]. Aynacioglu et al. [<xref ref-type="bibr" rid="B12">12</xref>] have also reported that the frequency of GSTP1 Val homozygote was significantly lower in the group of patients with asthma than in the control individuals (3.8% <italic>versus</italic> 12.1%, <italic>P</italic> = .01). On the other hand, a recent study [<xref ref-type="bibr" rid="B11">11</xref>] has found that the GSTP1 Val/Val was more prevalent among asthmatic subjects than the control group (22.8% and 7.8%, respectively) and that subjects with the GSTP1 homozygous Val/Val genotype had a 3.55-fold increased risk of having atopic asthma compared to nonatopic asthma (OR = 3.55; 95% CI, 1.10&#x02013;12.56), see [<xref ref-type="bibr" rid="B11">11</xref>]. Although, the <italic>GSTP1</italic>-derived enzyme contributes more than 90% of <italic>GST</italic> activity [<xref ref-type="bibr" rid="B36">36</xref>], it has been found by many studies [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>&#x02013;<xref ref-type="bibr" rid="B15">15</xref>] and confirmed by our finding that it protects children against developing asthma disease. Nevertheless, it has been reported that the Val105 variant has higher catalytic efficiency for polycyclic aromatic hydrocarbon diol epoxides but its efficiency for 1-chloro-2, 4-dinitrobenzene is lower compared to the Ile105 variant [<xref ref-type="bibr" rid="B37">37</xref>]. Therefore, it seems to be possible that <italic>GSTP1</italic> plays a role in asthma disease by modulation of ROS production.</p><p>In this study, for <italic>GSTT1</italic> null genotype, significant association was found between atopic asthmatic children and nonatopic asthmatic children (<italic>P</italic> = .008), see (<xref ref-type="table" rid="T2">Table 2</xref>). While our findings are substantiated by several studies on Caucasians populations [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B33">33</xref>], other studies were unable to establish this association [<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B38">38</xref>]. Several studies have suggested that individuals with the <italic>GSTT1</italic>*0/*0 <italic> (GSTT1 null)</italic> genotype may be more susceptible to genotoxic damage and lung diseases than individuals with the <italic>GSTT1</italic> gene [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B39">39</xref>].</p><p>Contradictory results were found in regards to <italic>GSTT1</italic>, <italic>GSTP1</italic>, and <italic>GSTM1</italic> [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B39">39</xref>]; ethnicity is the most important reason for these differences. That is why we have taken into consideration inter- and intraethnic characteristics in analyzing our findings.</p><p>In control populations with intra- and interethnic differences, frequent genetic deletion polymorphisms of <italic>GSTM1</italic> (<italic>GSTM1</italic>*0/*0) and <italic>GSTT1</italic> (<italic>GSTT1</italic>*0/*0) have been reported [<xref ref-type="bibr" rid="B5">5</xref>]. The distribution of the <italic>GSTM1</italic> null genotype and <italic>GSTT1</italic> null of our healthy control sample was found to be 50.2% and 29.5%, respectively, see (<xref ref-type="table" rid="T2">Table 2</xref>).</p><p>The frequency of <italic>GSTM1</italic> null genotype in our healthy controls (50.2%) seems to be within the frequency range reported for the Caucasian populations (<xref ref-type="table" rid="T4">Table 4</xref>). In fact, the <italic>GSTM1</italic> deletion frequencies range, respectively, from 50.4% to 58.00%, 49% to 63%, and 20% to 33% in Caucasian, Asiatic, and African control groups [<xref ref-type="bibr" rid="B5">5</xref>].</p><p>Regarding <italic>GSTT1</italic> null type, the frequency of deletion genotype in our Tunisian control group is set at 29.5%. Like the Egyptian population, Tunisia has a slightly higher frequency than that registered by Caucasian Europeans (between 13% and 22.3%) and Africans (between 19% and 26%). The frequency of the deletion genotype in the Tunisian population is closer to that of the Caucasian Americans (10%&#x02013;36%) and is considerably lower than that reported for the Asiatic populations (45% to 53%).</p><p>In conclusion, we have demonstrated that polymorphisms of <italic>GST</italic> genes previously found to be associated with asthma and atopy in Caucasian and Asiatic subjects are also associated with asthma and atopy in Tunisian children. Therefore, <italic>GST</italic> genotypes may be useful in order to optimize future treatment of asthma in the cases of patients with a risk profile.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We are particularly grateful to all the children that participated in this study and we wish to thank them. This work was supported by a grant from the Minist&#x000e8;re de l'Enseignement et de la Recherche Scientifique: DGRST.</p></ack><glossary><title>ABBREVIATIONS</title><def-list id="DL1"><def-item><term><italic>GST:</italic></term><def><p>Glutathione-S-transferase</p></def></def-item><def-item><term>OR:</term><def><p>Odds ratio</p></def></def-item><def-item><term>ROS:</term><def><p>Reactive oxygen species</p></def></def-item><def-item><term>PCR-RFLP:</term><def><p>Restriction length polymorphism</p></def></def-item><def-item><term>PCR:</term><def><p>Polymerase chain reaction</p></def></def-item></def-list></glossary><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kabesch</surname><given-names>M</given-names></name><name><surname>Hoefler</surname><given-names>C</given-names></name><name><surname>Carr</surname><given-names>D</given-names></name><name><surname>Leupold</surname><given-names>W</given-names></name><name><surname>Weiland</surname><given-names>SK</given-names></name><name><surname>von Mutius</surname><given-names>E</given-names></name></person-group><article-title>Glutathione S-transferase deficiency and passive smoking increase childhood asthma</article-title><source><italic>Thorax</italic></source><year>2004</year><volume>59</volume><issue>7</issue><fpage>569</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">15223862</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lazarus</surname><given-names>R</given-names></name><name><surname>Kleinman</surname><given-names>KP</given-names></name><name><surname>Dashevsky</surname><given-names>I</given-names></name><name><surname>DeMaria</surname><given-names>A</given-names></name><name><surname>Platt</surname><given-names>R</given-names></name></person-group><article-title>Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection</article-title><source><italic>BMC Public Health</italic></source><year>2001</year><volume>1</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11208260</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ober</surname><given-names>C</given-names></name><name><surname>Tsalenko</surname><given-names>A</given-names></name><name><surname>Parry</surname><given-names>R</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name></person-group><article-title>A second-generation genomewide screen for asthma-susceptibility alleles in a founder population</article-title><source><italic>American Journal of Human Genetics</italic></source><year>2000</year><volume>67</volume><issue>5</issue><fpage>1154</fpage><lpage>1162</lpage><pub-id pub-id-type="pmid">11022011</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pillay</surname><given-names>V</given-names></name><name><surname>Gaillard</surname><given-names>M-C</given-names></name><name><surname>Halkas</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Dewar</surname><given-names>JB</given-names></name></person-group><article-title>Differences in the genotypes and plasma concentrations of the interleukin-1 receptor antagonist in black and white South African asthmatics and control subjects</article-title><source><italic>Cytokine</italic></source><year>2000</year><volume>12</volume><issue>6</issue><fpage>819</fpage><lpage>821</lpage><pub-id pub-id-type="pmid">10843772</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garte</surname><given-names>S</given-names></name><name><surname>Gaspari</surname><given-names>L</given-names></name><name><surname>Alexandrie</surname><given-names>A-K</given-names></name><etal/></person-group><article-title>Metabolic gene polymorphism frequencies in control populations</article-title><source><italic>Cancer Epidemiology Biomarkers and Prevention</italic></source><year>2001</year><volume>10</volume><issue>12</issue><fpage>1239</fpage><lpage>1248</lpage></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>JD</given-names></name><name><surname>Pulford</surname><given-names>DJ</given-names></name></person-group><article-title>The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance</article-title><source><italic>Critical Reviews in Biochemistry and Molecular Biology</italic></source><year>1995</year><volume>30</volume><issue>6</issue><fpage>445</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">8770536</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strange</surname><given-names>RC</given-names></name><name><surname>Jones</surname><given-names>PW</given-names></name><name><surname>Fryer</surname><given-names>AA</given-names></name></person-group><article-title>Glutathione S-transferase: genetics and role in toxicology</article-title><source><italic>Toxicology Letters</italic></source><year>2000</year><volume>112-113</volume><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">10720752</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cotton</surname><given-names>SC</given-names></name><name><surname>Sharp</surname><given-names>L</given-names></name><name><surname>Little</surname><given-names>J</given-names></name><name><surname>Brockton</surname><given-names>N</given-names></name></person-group><article-title>Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review</article-title><source><italic>American Journal of Epidemiology</italic></source><year>2000</year><volume>151</volume><issue>1</issue><fpage>7</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">10625170</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fryer</surname><given-names>AA</given-names></name><name><surname>Bianco</surname><given-names>A</given-names></name><name><surname>Hepple</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>PW</given-names></name><name><surname>Strange</surname><given-names>RC</given-names></name><name><surname>Spiteri</surname><given-names>MA</given-names></name></person-group><article-title>Polymorphism at the glutathione S-transferase GSTP1 locus: a new marker for bronchial hyperresponsiveness and asthma</article-title><source><italic>American Journal of Respiratory and Critical Care Medicine</italic></source><year>2000</year><volume>161</volume><issue>5</issue><fpage>1437</fpage><lpage>1442</lpage><pub-id pub-id-type="pmid">10806136</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y-L</given-names></name><name><surname>Lin</surname><given-names>Y-C</given-names></name><name><surname>Lee</surname><given-names>Y-C</given-names></name><name><surname>Wang</surname><given-names>J-Y</given-names></name><name><surname>Hsiue</surname><given-names>T-R</given-names></name><name><surname>Guo</surname><given-names>YL</given-names></name></person-group><article-title>Glutathione S-transferase P1 gene polymorphism and air pollution as interactive risk factors for childhood asthma</article-title><source><italic>Clinical and Experimental Allergy</italic></source><year>2004</year><volume>34</volume><issue>11</issue><fpage>1707</fpage><lpage>1713</lpage><pub-id pub-id-type="pmid">15544594</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamer</surname><given-names>L</given-names></name><name><surname>&#x000c7;aliko&#x0011f;lu</surname><given-names>M</given-names></name><name><surname>Ates</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma</article-title><source><italic>Respirology</italic></source><year>2004</year><volume>9</volume><issue>4</issue><fpage>493</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">15612961</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aynacioglu</surname><given-names>AS</given-names></name><name><surname>Nacak</surname><given-names>M</given-names></name><name><surname>Filiz</surname><given-names>A</given-names></name><name><surname>Ekinci</surname><given-names>E</given-names></name><name><surname>Roots</surname><given-names>I</given-names></name></person-group><article-title>Protective role of glutathione S-transferase P1 (GSTP1) Val105Val genotype in patients with bronchial asthma</article-title><source><italic>British Journal of Clinical Pharmacology</italic></source><year>2004</year><volume>57</volume><issue>2</issue><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">14748821</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spiteri</surname><given-names>MA</given-names></name><name><surname>Bianco</surname><given-names>A</given-names></name><name><surname>Strange</surname><given-names>RC</given-names></name><name><surname>Fryer</surname><given-names>AA</given-names></name></person-group><article-title>Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation</article-title><source><italic>Allergy</italic></source><year>2000</year><volume>55</volume><issue>61</issue><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">10919500</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemmingsen</surname><given-names>A</given-names></name><name><surname>Fryer</surname><given-names>AA</given-names></name><name><surname>Hepple</surname><given-names>M</given-names></name><name><surname>Strange</surname><given-names>RC</given-names></name><name><surname>Spiteri</surname><given-names>MA</given-names></name></person-group><article-title>Simultaneous identification of GSTP1 Ile105 &#x02192; Val105 and Ala114 &#x02192; Val114 substitutions using an amplification refractory mutation system polymerase chain reaction assay: studies in patients with asthma</article-title><source><italic>Respiratory Research</italic></source><year>2001</year><volume>2</volume><issue>4</issue><fpage>255</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">11686891</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mapp</surname><given-names>CE</given-names></name><name><surname>Fryer</surname><given-names>AA</given-names></name><name><surname>De Marzo</surname><given-names>N</given-names></name><etal/></person-group><article-title>Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates</article-title><source><italic>Journal of Allergy and Clinical Immunology</italic></source><year>2002</year><volume>109</volume><issue>5</issue><fpage>867</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">11994713</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wikman</surname><given-names>H</given-names></name><name><surname>Piiril&#x000e4;</surname><given-names>P</given-names></name><name><surname>Rosenberg</surname><given-names>C</given-names></name><etal/></person-group><article-title>N-acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk</article-title><source><italic>Pharmacogenetics</italic></source><year>2002</year><volume>12</volume><issue>3</issue><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">11927838</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holla</surname><given-names>LI</given-names></name><name><surname>Stejskalova</surname><given-names>A</given-names></name><name><surname>Vasku</surname><given-names>A</given-names></name></person-group><article-title>Polymorphisms of the GSTM1 and GSTT1 genes in patients with allergic diseases in the Czech population</article-title><source><italic>Allergy</italic></source><year>2006</year><volume>61</volume><issue>2</issue><fpage>265</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">16409207</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>WD</given-names></name><name><surname>Lenney</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>PW</given-names></name><etal/></person-group><article-title>Effects of glutathione S-transferase M1, T1 and P1 on lung function in asthmatic families</article-title><source><italic>Clinical and Experimental Allergy</italic></source><year>2005</year><volume>35</volume><issue>9</issue><fpage>1155</fpage><lpage>1161</lpage><pub-id pub-id-type="pmid">16164441</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>SA</given-names></name><name><surname>Dykes</surname><given-names>DD</given-names></name><name><surname>Polesky</surname><given-names>HF</given-names></name></person-group><article-title>A simple salting out procedure for extracting DNA from human nucleated cells</article-title><source><italic>Nucleic Acids Research</italic></source><year>1988</year><volume>16</volume><issue>3</issue><fpage>1215</fpage><pub-id pub-id-type="pmid">3344216</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delom&#x000e9;nie</surname><given-names>C</given-names></name><name><surname>Mathelier-Fusade</surname><given-names>P</given-names></name><name><surname>Longuemaux</surname><given-names>S</given-names></name><etal/></person-group><article-title>Glutathione S-transferase (GSTM1) null genotype and sulphonamide intolerance in acquired immunodeficiency syndrome</article-title><source><italic>Pharmacogenetics</italic></source><year>1997</year><volume>7</volume><issue>6</issue><fpage>519</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">9429238</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seidegard</surname><given-names>J</given-names></name><name><surname>Vorachek</surname><given-names>WR</given-names></name><name><surname>Pero</surname><given-names>RW</given-names></name><name><surname>Pearson</surname><given-names>WR</given-names></name></person-group><article-title>Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1988</year><volume>85</volume><issue>19</issue><fpage>7293</fpage><lpage>7297</lpage><pub-id pub-id-type="pmid">3174634</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>DA</given-names></name><name><surname>Taylor</surname><given-names>JA</given-names></name><name><surname>Paulson</surname><given-names>DF</given-names></name><name><surname>Robertson</surname><given-names>CN</given-names></name><name><surname>Mohler</surname><given-names>JL</given-names></name><name><surname>Lucier</surname><given-names>GW</given-names></name></person-group><article-title>Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer</article-title><source><italic>Journal of the National Cancer Institute</italic></source><year>1993</year><volume>85</volume><issue>14</issue><fpage>1159</fpage><lpage>1164</lpage><pub-id pub-id-type="pmid">8320745</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harries</surname><given-names>LW</given-names></name><name><surname>Stubbins</surname><given-names>MJ</given-names></name><name><surname>Forman</surname><given-names>D</given-names></name><name><surname>Howard</surname><given-names>GCW</given-names></name><name><surname>Wolf</surname><given-names>CR</given-names></name></person-group><article-title>Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer</article-title><source><italic>Carcinogenesis</italic></source><year>1997</year><volume>18</volume><issue>4</issue><fpage>641</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">9111193</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamdy</surname><given-names>SI</given-names></name><name><surname>Hiratsuka</surname><given-names>M</given-names></name><name><surname>Narahara</surname><given-names>K</given-names></name><etal/></person-group><article-title>Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population</article-title><source><italic>British Journal of Clinical Pharmacology</italic></source><year>2003</year><volume>55</volume><issue>6</issue><fpage>560</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">12814450</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gatt&#x000e1;s</surname><given-names>GJF</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Soares-Vieira</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Ethnicity and glutathione S-transferase (GSTM1/GSTT1) polymorphisms in a Brazilian population</article-title><source><italic>Brazilian Journal of Medical and Biological Research</italic></source><year>2004</year><volume>37</volume><issue>4</issue><fpage>451</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">15064808</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamel</surname><given-names>N</given-names></name><name><surname>Karimi</surname><given-names>S</given-names></name><name><surname>H&#x000e9;bert-Blouin</surname><given-names>M-N</given-names></name><etal/></person-group><article-title>Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco</article-title><source><italic>International Journal of Cancer</italic></source><year>2000</year><volume>87</volume><issue>3</issue><fpage>452</fpage><lpage>454</lpage></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>MV</given-names></name><name><surname>Alvarez</surname><given-names>V</given-names></name><name><surname>Pello</surname><given-names>MF</given-names></name><name><surname>Men&#x000e9;ndez</surname><given-names>MJ</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>C</given-names></name><name><surname>Coto</surname><given-names>E</given-names></name></person-group><article-title>Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer</article-title><source><italic>Journal of Clinical Pathology</italic></source><year>1998</year><volume>51</volume><issue>4</issue><fpage>294</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">9659241</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matthias</surname><given-names>C</given-names></name><name><surname>Bockm&#x000fc;hl</surname><given-names>U</given-names></name><name><surname>Jahnke</surname><given-names>V</given-names></name><etal/></person-group><article-title>Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers</article-title><source><italic>Pharmacogenetics</italic></source><year>1998</year><volume>8</volume><issue>2</issue><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">10022746</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ada</surname><given-names>AO</given-names></name><name><surname>S&#x000fc;zen</surname><given-names>SH</given-names></name><name><surname>Iscan</surname><given-names>M</given-names></name></person-group><article-title>Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population</article-title><source><italic>Toxicology Letters</italic></source><year>2004</year><volume>151</volume><issue>1</issue><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">15177667</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rebbeck</surname><given-names>TR</given-names></name></person-group><article-title>Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility</article-title><source><italic>Cancer Epidemiology Biomarkers and Prevention</italic></source><year>1997</year><volume>6</volume><issue>9</issue><fpage>733</fpage><lpage>743</lpage></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benhamou</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>WJ</given-names></name><name><surname>Alexandrie</surname><given-names>A-K</given-names></name><etal/></person-group><article-title>Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk</article-title><source><italic>Carcinogenesis</italic></source><year>2002</year><volume>23</volume><issue>8</issue><fpage>1343</fpage><lpage>1350</lpage><pub-id pub-id-type="pmid">12151353</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benhamou</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>WJ</given-names></name><name><surname>Alexandrie</surname><given-names>A-K</given-names></name><etal/></person-group><article-title>Erratum: meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk</article-title><source><italic>Carcinogenesis</italic></source><year>2002</year><volume>23</volume><issue>10</issue><fpage>1771</fpage><lpage>1172</lpage></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brasch-Andersen</surname><given-names>C</given-names></name><name><surname>Christiansen</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>Q</given-names></name><name><surname>Haagerup</surname><given-names>A</given-names></name><name><surname>Vestbo</surname><given-names>J</given-names></name><name><surname>Kruse</surname><given-names>TA</given-names></name></person-group><article-title>Possible gene dosage effect of glutathione-S-transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers</article-title><source><italic>Human Mutation</italic></source><year>2004</year><volume>24</volume><issue>3</issue><fpage>208</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">15300848</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivaschenko</surname><given-names>TE</given-names></name><name><surname>Sideleva</surname><given-names>OG</given-names></name><name><surname>Baranov</surname><given-names>VS</given-names></name></person-group><article-title>Glutathione-S-transferase <italic>&#x003bc;</italic> and theta gene polymorphisms as new risk factors of atopic bronchial asthma</article-title><source><italic>Journal of Molecular Medicine</italic></source><year>2002</year><volume>80</volume><issue>1</issue><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11862323</pub-id></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandford</surname><given-names>AJ</given-names></name><name><surname>Chan</surname><given-names>HW</given-names></name><name><surname>Wong</surname><given-names>GWK</given-names></name><name><surname>Lai</surname><given-names>CKW</given-names></name><name><surname>Chan-Yeung</surname><given-names>M</given-names></name></person-group><article-title>Candidate genetic polymorphisms for asthma in Chinese schoolchildren from Hong Kong</article-title><source><italic>International Journal of Tuberculosis and Lung Disease</italic></source><year>2004</year><volume>8</volume><issue>5</issue><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">15137526</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fryer</surname><given-names>AA</given-names></name><name><surname>Hume</surname><given-names>R</given-names></name><name><surname>Strange</surname><given-names>RC</given-names></name></person-group><article-title>The development of glutathione S-transferase and glutathione peroxidase activities in human lung</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>1986</year><volume>883</volume><issue>3</issue><fpage>448</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">3756211</pub-id></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>MA</given-names></name><name><surname>Stewart</surname><given-names>RK</given-names></name><name><surname>Smith</surname><given-names>GBJ</given-names></name><name><surname>Massey</surname><given-names>TE</given-names></name><name><surname>Bell</surname><given-names>DA</given-names></name></person-group><article-title>Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution</article-title><source><italic>Carcinogenesis</italic></source><year>1998</year><volume>19</volume><issue>2</issue><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">9498276</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fre&#x0012d;din</surname><given-names>MB</given-names></name><name><surname>Bragina</surname><given-names>EI</given-names></name><name><surname>Ogorodova</surname><given-names>LM</given-names></name><name><surname>Puzyrev</surname><given-names>VP</given-names></name></person-group><article-title>Polymorphism of the theta1 and mu1 glutathione S-transferase genes (GSTT1, GSTM1) in patients with atopic bronchial asthma from the West Siberian region</article-title><source><italic>Molekulyarnaya Biologiya</italic></source><year>2002</year><volume>36</volume><issue>4</issue><fpage>630</fpage><lpage>634</lpage></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stanulla</surname><given-names>M</given-names></name><name><surname>Schrappe</surname><given-names>M</given-names></name><name><surname>Brechlin</surname><given-names>AM</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Welte</surname><given-names>K</given-names></name></person-group><article-title>Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study</article-title><source><italic>Blood</italic></source><year>2000</year><volume>95</volume><issue>4</issue><fpage>1222</fpage><lpage>1228</lpage><pub-id pub-id-type="pmid">10666194</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The clinical characteristics.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Cases <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">Controls <italic>n</italic> (%)</td></tr><tr><td colspan="4" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">62 (59)</td><td align="center" rowspan="1" colspan="1">62 (55.3)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">43 (41)</td><td align="center" rowspan="1" colspan="1">50 (44.7)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Sex ratio (female/male)</td><td align="center" rowspan="1" colspan="1">0.69</td><td align="center" rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mean age (standard deviation)</td><td align="center" rowspan="1" colspan="1">11.5 (5&#x02013;16)</td><td align="center" rowspan="1" colspan="1">9.5 (5&#x02013;16)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">FEV1 (% predicted)<xref ref-type="table-fn" rid="TF2">**</xref></td><td align="center" rowspan="1" colspan="1">96.1 &#x000b1; 14.2</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">FVC (% predicted)<xref ref-type="table-fn" rid="TF3">***</xref></td><td align="center" rowspan="1" colspan="1">97.4 &#x000b1; 14.6</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Atopic</td><td align="center" rowspan="1" colspan="1">73 (70.32)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Nonatopic</td><td align="center" rowspan="1" colspan="1">32 (29.68)</td><td align="center" rowspan="1" colspan="1">112 (100)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Passive smoking</td><td align="center" rowspan="1" colspan="1"><italic>n</italic>(35)</td><td align="center" rowspan="1" colspan="1"><italic>n</italic>(22)</td></tr><tr><td colspan="4" rowspan="1"><hr/></td></tr><tr><td rowspan="6" colspan="1">Phenotypes associated</td><td rowspan="1" colspan="1">Rhinitis</td><td align="center" rowspan="1" colspan="1">15 (14.28)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Sinusitis</td><td align="center" rowspan="1" colspan="1">7 (6.66)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Dermatitis</td><td align="center" rowspan="1" colspan="1">5 (4.76)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">RGO<xref ref-type="table-fn" rid="TF1">*</xref></td><td align="center" rowspan="1" colspan="1">8 (7.61)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Asthma, dermatitis, and rhinitis</td><td align="center" rowspan="1" colspan="1">7 (6.66)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Asthma, sinusitis, and rhinitis</td><td align="center" rowspan="1" colspan="1">5 (4.76)</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>*RGO: gastro-esophageal reflux.</p></fn><fn id="TF2"><p>**FEV1: forced expiratory volume in 1 second.</p></fn><fn id="TF3"><p>***FVC: forced vital capacity; ND, not determined.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Association of genotype profile between asthmatics and controls. NS: <italic>P</italic> value &#x0003e; .05.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" colspan="11" rowspan="1">Asthmatics Controls</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1">Gene</td><td rowspan="1" colspan="1">Chromosomal location</td><td align="center" rowspan="1" colspan="1">Polymorphisms</td><td align="center" rowspan="1" colspan="1">Genotypes</td><td align="center" rowspan="1" colspan="1">(<italic>n</italic> = 105)</td><td align="center" rowspan="1" colspan="1">(%)</td><td align="center" rowspan="1" colspan="1">(<italic>n</italic> = 112)</td><td align="center" rowspan="1" colspan="1">(%)</td><td align="center" rowspan="1" colspan="1">OR</td><td align="center" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> value</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="2" colspan="1"><italic>GSTM1</italic></td><td align="center" rowspan="2" colspan="1">1p13</td><td align="center" rowspan="2" colspan="1">Null allele</td><td align="center" rowspan="1" colspan="1">Null</td><td align="center" rowspan="1" colspan="1">79</td><td align="center" rowspan="1" colspan="1">70.7</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">50.2</td><td align="center" rowspan="2" colspan="1">2.35</td><td align="center" rowspan="2" colspan="1">1.30&#x02013;4.27</td><td align="center" rowspan="2" colspan="1">.002</td></tr><tr><td align="center" rowspan="1" colspan="1">WT</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">29.3</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">49.8</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="2" colspan="1"><italic>GSTT1</italic></td><td align="center" rowspan="2" colspan="1">22q11</td><td align="center" rowspan="2" colspan="1">Null allele</td><td align="center" rowspan="1" colspan="1">Null</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">29.5</td><td align="center" rowspan="2" colspan="1">1.43</td><td align="center" rowspan="2" colspan="1">0.78&#x02013;2.63</td><td align="center" rowspan="2" colspan="1">NS</td></tr><tr><td align="center" rowspan="1" colspan="1">WT</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">62.5</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">70.5</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="5" colspan="1"><italic>GSTP1</italic></td><td align="center" rowspan="5" colspan="1">11q13</td><td align="center" rowspan="5" colspan="1">Ile105Val</td><td align="center" rowspan="1" colspan="1">Ile/Ile</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">43.8</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">34.4</td><td align="center" rowspan="1" colspan="1">1.32</td><td align="center" rowspan="1" colspan="1">0.70&#x02013;2.47</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="center" rowspan="1" colspan="1">Ile/Val</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">45.5</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">47.1</td><td align="center" rowspan="1" colspan="1">1.77</td><td align="center" rowspan="1" colspan="1">0.73&#x02013;4.35</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="center" rowspan="1" colspan="1">Val/Val</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">10.7</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">18.6</td><td align="center" rowspan="1" colspan="1">2.33</td><td align="center" rowspan="1" colspan="1">0.94&#x02013;5.87</td><td align="center" rowspan="1" colspan="1">.04</td></tr><tr><td align="center" rowspan="1" colspan="1">A(Ile)</td><td align="center" rowspan="1" colspan="1">149</td><td align="center" rowspan="1" colspan="1">66.5</td><td align="center" rowspan="1" colspan="1">118</td><td align="center" rowspan="1" colspan="1">56.2</td><td align="center" rowspan="2" colspan="1">1.55</td><td align="center" rowspan="2" colspan="1">1.03&#x02013;2.33</td><td align="center" rowspan="2" colspan="1">.027</td></tr><tr><td align="center" rowspan="1" colspan="1">G(Val)</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1">33.5</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">43.8</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Association between genotype profile and atopic asthma. NS: <italic>P</italic> value &#x0003e; .05.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="2" rowspan="1">Atopic asthmatics</td><td align="center" colspan="2" rowspan="1">Nonatopic asthmatics</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1">Gene</td><td align="center" rowspan="1" colspan="1">Chromosomal location</td><td align="center" rowspan="1" colspan="1">Polymorphisms</td><td align="center" rowspan="1" colspan="1">Genotypes</td><td align="center" rowspan="1" colspan="1">(<italic>n</italic> = 73)</td><td align="center" rowspan="1" colspan="1">%</td><td align="center" rowspan="1" colspan="1">(<italic>n</italic> = 32)</td><td align="center" rowspan="1" colspan="1">%</td><td align="center" rowspan="1" colspan="1">OR</td><td align="center" rowspan="1" colspan="1">95%CI</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> value</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="2" colspan="1"><italic>GSTM1</italic></td><td align="center" rowspan="2" colspan="1">1p13</td><td align="center" rowspan="2" colspan="1">Null allele</td><td align="center" rowspan="1" colspan="1">Null</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">50.7</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">40.6</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="2" colspan="1">NS</td></tr><tr><td align="center" rowspan="1" colspan="1">WT</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">49.3</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">59.4</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">0.6&#x02013;3.80</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="2" colspan="1"><italic>GSTT1</italic></td><td align="center" rowspan="2" colspan="1">22q11</td><td align="center" rowspan="2" colspan="1">Null allele</td><td align="center" rowspan="1" colspan="1">Null</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">49.31</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">21.8</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="2" colspan="1">.008</td></tr><tr><td align="center" rowspan="1" colspan="1">WT</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">50.69</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">78.12</td><td align="center" rowspan="1" colspan="1">3.74</td><td align="center" rowspan="1" colspan="1">1.23&#x02013;10.15</td></tr><tr><td colspan="11" rowspan="1"><hr/></td></tr><tr><td rowspan="5" colspan="1"><italic>GSTP1</italic></td><td align="center" rowspan="5" colspan="1">11q13</td><td align="center" rowspan="5" colspan="1">Ile105Val</td><td align="center" rowspan="1" colspan="1">Ile/Ile</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">42.5</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">43.0</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" rowspan="1" colspan="1">Ile/Val</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">46.50</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">40.0</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.31&#x02013;2.41</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="center" rowspan="1" colspan="1">Val/Val</td><td align="center" rowspan="1" colspan="1">08</td><td align="center" rowspan="1" colspan="1">11.00</td><td align="center" rowspan="1" colspan="1">07</td><td align="center" rowspan="1" colspan="1">23.3</td><td align="center" rowspan="1" colspan="1">1.85</td><td align="center" rowspan="1" colspan="1">0.49&#x02013;7.08</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="center" rowspan="1" colspan="1">A(Ile)</td><td align="center" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">59.4</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" rowspan="1" colspan="1">G(Val)</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">40.6</td><td align="center" rowspan="1" colspan="1">1.27</td><td align="center" rowspan="1" colspan="1">0.67&#x02013;2.43</td><td align="center" rowspan="1" colspan="1">NS</td></tr></tbody></table></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Comparison frequencies of <italic>GSTM1</italic> and <italic>GSTT1</italic> gene polymorphisms in Caucasian control populations.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1">Country</td><td align="center" rowspan="1" colspan="1"><italic>GSTM1</italic> null</td><td align="center" rowspan="1" colspan="1"><italic>GSTT1</italic> null</td><td align="center" rowspan="1" colspan="1">Reference</td></tr><tr><td colspan="4" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1">Tunisia</td><td align="center" rowspan="1" colspan="1">50.33% (105)<xref ref-type="table-fn" rid="TF4">*</xref></td><td align="center" rowspan="1" colspan="1">29.50% (105)</td><td align="center" rowspan="1" colspan="1">Present study</td></tr><tr><td rowspan="1" colspan="1">Egypt</td><td align="center" rowspan="1" colspan="1">55.50% (200)</td><td align="center" rowspan="1" colspan="1">29.50% (300)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B24">24</xref>]</td></tr><tr><td rowspan="1" colspan="1">United Kingdom</td><td align="center" rowspan="1" colspan="1">57.80% (1122)</td><td align="center" rowspan="1" colspan="1">20.50% (922)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B5">5</xref>]</td></tr><tr><td rowspan="1" colspan="1">Sweden</td><td align="center" rowspan="1" colspan="1">55.90% (544)</td><td align="center" rowspan="1" colspan="1">13.00% (423)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B5">5</xref>]</td></tr><tr><td rowspan="1" colspan="1">France</td><td align="center" rowspan="1" colspan="1">53.40% (1184)</td><td align="center" rowspan="1" colspan="1">16.80% (512)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B5">5</xref>]</td></tr><tr><td rowspan="1" colspan="1">WhiteBrazilians</td><td align="center" rowspan="1" colspan="1">55.50% (233)</td><td align="center" rowspan="1" colspan="1">22.30% (233)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B25">25</xref>]</td></tr><tr><td rowspan="1" colspan="1">Canada</td><td align="center" rowspan="1" colspan="1">58.00% (90)</td><td align="center" rowspan="1" colspan="1">22.00% (90)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B26">26</xref>]</td></tr><tr><td rowspan="1" colspan="1">Spain</td><td align="center" rowspan="1" colspan="1">54.00% (200)</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B27">27</xref>]</td></tr><tr><td rowspan="1" colspan="1">Netherlands</td><td align="center" rowspan="1" colspan="1">50.40% (419)</td><td align="center" rowspan="1" colspan="1">22.90% (419)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B5">5</xref>]</td></tr><tr><td rowspan="1" colspan="1">Germany</td><td align="center" rowspan="1" colspan="1">53.00% (219)</td><td align="center" rowspan="1" colspan="1">20.00% (219)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B28">28</xref>]</td></tr><tr><td rowspan="1" colspan="1">Turkey</td><td align="center" rowspan="1" colspan="1">51.90% (133)</td><td align="center" rowspan="1" colspan="1">17.30% (133)</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B29">29</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="TF4"><p>* Numbers between brackets represent the sample size; ND, not determined.</p></fn></table-wrap-foot></table-wrap></sec></back></article> 